Company: GMRE
Filing Date: 2025-11-14
Form Type: 424B5
Source: 0001104659-25-112543
Chunk: 18

Company: Global Medical REIT Inc.
Filing Date: 2025-11-14
Form: 424B5
Chunk 18
---
 right to vote as a class on certain fundamental matters that may affect the preference or special rights
of the Series B Preferred Stock, as described under “Description of Series B Preferred Stock — Voting Rights.”
In addition, if dividends on the Series B Preferred Stock, or any other parity equity shares (as defined in “Description of
Series B Preferred Stock — Ranking”), including our Series A Preferred Stock, have not been declared or paid for
the equivalent of six or more dividend payments, whether or not for consecutive dividend periods, the holders of such shares, voting together
as a class with holders of any and all other series of voting preferred stock on parity with the Series B Preferred Stock then outstanding,
will be entitled to vote for the election of a total of two additional directors of our Board of Directors, subject to the terms and to
the limited extent described under “Description of Series B Preferred Stock — Voting Rights.” The Series B
Preferred Stock place no restrictions on our business or operations or on our ability to incur indebtedness or engage in any transactions,
subject only to the limited voting rights referred to above. See “Description of Series B Preferred Stock — Voting Rights.”

You may not be permitted to exercise conversion rights upon a Change of Control. If exercisable, the Change of Control conversion feature of our Series B Preferred Stock may not adequately compensate you and may make it more difficult for a third party to take over the Company or discourage a third party from taking over the Company.

Upon the occurrence of a Change of Control, holders
of our Series B Preferred Stock will have the right (unless, prior to the Change of Control Conversion Date, we have provided or
provide notice of our election to redeem our Series B Preferred Stock) to convert some or all of their Series B Preferred Stock
into our common stock (or equivalent value of alternative consideration). See “Description of Series B Preferred Stock —
Conversion Right upon a Change of Control.” Upon such a conversion, the holders will be limited to a maximum number of shares of
our common stock per share of Series B Preferred Stock equal to the lesser of (i) the conversion value (equal to the liquidation
preference and unpaid and accrued dividends) divided by the closing price on the date of the event triggering the Change of Control and
(ii) the Share Cap, subject to adjustments, which may result in a holder receiving value that is less than the liquidation preference
of the Series B Preferred Stock. In addition, these features of the Series B Preferred Stock may have the effect of